CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 1.03 USD 1.98% Market Closed
Market Cap: 80.5m USD
Have any thoughts about
CytomX Therapeutics Inc?
Write Note

Net Margin
CytomX Therapeutics Inc

10.9%
Current
-199%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
13.8m
/
Revenue
126.6m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
US
CytomX Therapeutics Inc
NASDAQ:CTMX
80.6m USD
11%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
300.2B USD
9%
US
Amgen Inc
NASDAQ:AMGN
158.7B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.8B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
137.3B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.3B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.1B EUR
-14%
Country US
Market Cap 80.6m USD
Net Margin
11%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 300.2B USD
Net Margin
9%
Country US
Market Cap 158.7B USD
Net Margin
13%
Country US
Market Cap 126.8B USD
Net Margin
-5%
Country US
Market Cap 115B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 88.3B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for CytomX Therapeutics Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
13.8m
/
Revenue
126.6m
What is the Net Margin of CytomX Therapeutics Inc?

Based on CytomX Therapeutics Inc's most recent financial statements, the company has Net Margin of 10.9%.